Study of Tomography of Nephrolithiasis Evaluation (STONE)

This study is currently recruiting participants.
Verified January 2013 by University of California, San Francisco
Sponsor:
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01451931
First received: October 11, 2011
Last updated: January 31, 2013
Last verified: January 2013
  Purpose

This is a multi-center, randomized controlled trial of ultrasonography (ultrasound) compared to computed tomography (CT) for the initial emergency room evaluation of patients with suspected renal colic. The investigators will compare several measures of effectiveness including morbidity related to the patient's underlying disease, or complications related to delayed diagnosis, patient status regarding pain/missed days of work, and utilization of health care resources based on one of three study arms: ultrasound in the Emergency Department, ultrasound in Radiology or CT.


Condition Intervention Phase
Urolithiasis
Other: Diagnostic ultrasonography in radiology department
Radiation: CT in Radiology
Other: Ultrasonography in the Emergency Department
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Randomized Controlled Trial of Ultrasound Versus CT (Computed Tomography) for Patients in the Emergency Department With Suspected Renal Colic

Resource links provided by NLM:


Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • Effectiveness [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
    Compare morbidity outcomes as they vary by imaging assignment to one the three study arms. The primary outcome data are reports of adverse events during follow up and any complications primarily complications that could result from missed diagnoses. We will define the rate of adverse events as including any of the following: renal infarction, renal abscess, urosepsis, ruptured appendicitis, diverticulitis with abscess, ruptured aortic aneurysm, thoracic dissection with ischemia or death.


Secondary Outcome Measures:
  • Radiation Dose [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
    Compare the average effective dose of ionizing radiation based on imaging tests received and patient's randomization status.

  • Cost [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Compare the direct health care costs within 9 months following each ED encounter, based on patient's randomization to one of the three study arms.


Estimated Enrollment: 2500
Study Start Date: September 2011
Estimated Study Completion Date: September 2013
Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Ultrasonography Emergency Department
Patient with suspected urolithiasis will receive ultrasonography performed in the emergency department.
Other: Ultrasonography in the Emergency Department
Perform ultrasonography in the ED (physician).
Experimental: Ultrasonograpy Radiology
Patient with suspected urolithiasis will receive diagnostic ultrasonography in the radiology department.
Other: Diagnostic ultrasonography in radiology department
Diagnostic ultrasound completed in the radiology department at time 0.
Experimental: CT in Radiology
Patient with suspected urolithiasis will receive computed tomography in the radiology department.
Radiation: CT in Radiology
Computed tomography of abdomen completed in the radiology department at time 0.

Detailed Description:

This is a multi-center, randomized controlled trial of ultrasonography compared with computed tomography (CT) for the evaluation of patients with suspected urolithiasis. The study will be conducted at 10 large urban Emergency Departments (EDs), reflecting geographic, socioeconomic, racial and ethnic diversity, and include academic medical centers as well as safety net hospitals. The patients will be randomized to one of three arms: 1) ultrasound in the Emergency Department (ED), 2) ultrasound in radiology or 3) CT in radiology. The investigators will then collect precise and unbiased data on a comprehensive range of outcomes that will allow assessment of effectiveness, safety, accuracy and cost between patients randomized to one the three groups. Taken together, these measures are intended to provide the basis for a valid comparison of imaging of patients with suspected urolithiasis seen in the ED. The results of this trial could lead to a change in clinical practice that is associated with both improved patient outcomes and reduced cost. Broad stakeholder involvement from within radiology, emergency medicine and several subspecialty communities has been sought to ensure the strategic completion of study aims and to help rapidly disseminate the results of the study into clinical practice. This will create a collaborative network of EDs willing to act as a laboratory for studying the comparative effectiveness of diagnostic testing. As a result, the proposed trial will demonstrate the feasibility of conducting RCT of imaging that incorporates measurements of outcomes that can be expanded to additional imaging tests in the future.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • subjects = or >18 years of age presenting with acute renal colic
  • symptoms consistent for and with suspicion of renal colic: acute flank pain radiating to the abdomen or groin, colicky in nature, hematuria
  • physical exam consistent with renal colic : ie CVA tenderness.
  • laboratory examination will consistent with urolithiasis-- microscopic hematuria.

Exclusion Criteria:

  • children < 18 years old
  • elderly patients > 65 years old
  • pregnancy
  • hemodynamically unstable HR>100 bpm; SBP < 90; RR > 18
  • Morbid obesity
  • patients with an acute abdomen, signs of sepsis, signs of alternate diagnosis (ie appendicitis, abdominal aortic aneurysm, pyelonephritis).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01451931

Contacts
Contact: Rebecca Smith-Bindman, MD 415-353-4946 rebecca.smith-bindman@ucsf.edu
Contact: Victoria Valencia, MPH 415-502-7625 victoria.valencia@ucsf.edu

Locations
United States, California
UCSF at Fresno Recruiting
Fresno, California, United States, 93701
Contact: Jessica Weidenbach     559-499-6440     JWeidenbach@fresno.ucsf.edu    
University of California, Davis Active, not recruiting
Sacramento, California, United States, 95817
University of California, San Francisco Active, not recruiting
San Francisco, California, United States, 94143
United States, Georgia
Grady Memorial Hospital Active, not recruiting
Atlanta, Georgia, United States, 30303
United States, Illinois
John H. Stroger Jr. Hospital of Cook County Recruiting
Chicago, Illinois, United States, 60612
Contact: John Bailitz, M.D.     312-864-0198     johnbailitz@gmail.com    
United States, Massachusetts
Massachusetts General Hospital Recruiting
Boston, Massachusetts, United States, 02114
Contact: Vicky Noble         VNOBLE@PARTNERS.ORG    
Beth Israel Deaconess Medical Center Active, not recruiting
Boston, Massachusetts, United States, 02215
United States, Minnesota
Hennepin County Medical Center Recruiting
Minneapolis, Minnesota, United States, 55415
Contact: Lila Steinberg     612-873-9528     Lila.Steinberg@hcmed.org    
United States, Missouri
Washington University School of Medicine Active, not recruiting
St. Louis, Missouri, United States, 63130
United States, New York
Jacobi Medical Center Recruiting
Bronx, New York, United States, 10461
Contact: Jill Corbo         jillcorbo@aol.com    
United States, Oregon
Oregon Health and Science University Active, not recruiting
Portland, Oregon, United States, 97239
United States, Pennsylvania
Hospital of the University of Pennsylvania Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Katie O'Conor     215-662-3908     Katie.OConor@uphs.upenn.edu    
United States, Rhode Island
Rhode Island Hospital Active, not recruiting
Providence, Rhode Island, United States, 02903
United States, Texas
University of Texas Houston Medical Center Active, not recruiting
Houston, Texas, United States, 77026
United States, Utah
University of Utah Recruiting
Salt Lake City, Utah, United States, 84132
Contact: Jacob Steenblik     801-585-1216     Jacob.steenblik@hsc.utah.edu    
Sponsors and Collaborators
University of California, San Francisco
Investigators
Principal Investigator: Rebecca Smith-Bindman, MD University of California, San Francisco, Department of Radiology and Biomedical Imaging
Study Chair: Clifford Rosen, MD Professor of Medicine, Tufts University (Data Safety Monitoring Board Chair)
  More Information

No publications provided

Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT01451931     History of Changes
Other Study ID Numbers: RSB-1002670
Study First Received: October 11, 2011
Last Updated: January 31, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, San Francisco:
kidney stone
urolithiasis
urinary tract infection
ultrasound
computed tomography
safety
cost
accuracy

Additional relevant MeSH terms:
Urolithiasis
Urologic Diseases

ClinicalTrials.gov processed this record on May 21, 2013